From 1 July 2004.

Research blood substitute in trauma patients to test at the scene of injuryLoyola University Health System test plans polyHEME, an investigational drug designed oxygen-carrying blood substitute to enhance the survival of severely injured and bleeding trauma patients at the scene? Injury, from 1 July 2004. As part of a national study.

Loyola is one of the 20 Level I trauma centers participating in the trial nationwide and the only one in Illinois. If the blood substitute works the way we hope it will, is not practical could be the first major advance since the introduction of saline, or salt water, the volume the volume of blood loss, around the time of World War I, said Dr. Richard L. Gamelli, principal investigator, Chairman, Department of Surgery and Professor of Trauma Surgery, Loyola University Chicago Stritch School of Medicine.. Loyola Institutional Review Board topics for the Protection of Human Rights and Research approved the clinical trial following extensive public education activities.The system is up to this point by this time by Teenage Cancer Trust, with additional support from CLIC Sargent, and has just been awarded further funding of Teenage Cancer Trust, so that work can to the fourth stage, to 150 youth in of six centers continued the United Kingdom: the Royal Marsden and the University College Hospital London, which Christie Hospital , James Hospital , and two other to be confirmed. That study, which is a new improved version of the system will begin in September and walk for 30 months. Hopes Dr. That there will rolled throughout the country so that everyone young cancer patients can benefit.